Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multisite, Randomized, Double-Blind, Placebo-Controlled, and Parallel Study to Evaluate the Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia (Qi Yin Deficiency)

NCT03201848 is registered in ClinicalTrials.gov with Qidong Gaitianli Medicines Co., Ltd as lead sponsor.

NCT NCT03201848
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03201848 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multisite, Randomized, Double-Blind, Placebo-Controlled, and Parallel Study to Evaluate the Efficacy and Safety of Huaiqihuang Granule in Children With Chronic Primary Immune Thrombocytopenia (Qi Yin Deficiency)
Lead sponsor
Qidong Gaitianli Medicines Co., Ltd
Phase
Phase 4
Overall status
Unknown status
Start date
November 16, 2017
Completion date
June 30, 2024
Enrollment
216 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenia